Primary epiploic appendagitis (PEA) is a rare cause of abdominal acute or subacute complaints. Diagnosis of PEA is made when computed tomography (CT) reveals a characteristic lesion. We report on contrast-enhanced CT images of a patient with PEA and regression of inflammation and the reduction in size of the inflamed appendage over the time period of 4 months. Patients with PEA usually recover without medication or surgical treatment within a few weeks. However, due to continuing bloating and irregular bowel movements we investigated carbohydrate malabsorption and diagnosed a fructose malabsorption. Bloating and irregular bowel movements in this patient with PEA were correlated to carbohydrate malabsorption and were treated successfully with a diet free of culprit carbohydrates.
INTRODUCTION
Primary epiploic appendagitis (PEA) is an uncommon, benign inflammatory process of epiploic appendages, which are adipose structures protruding from the colon. Owing to a lack of pathognomonic clinical features and awareness of the disease, PEA is rarely diagnosed as the cause of acute and subacute abdominal complaints. 1 Over the past 10 years recognition of PEA has increased due to the use of cross-sectional-imaging computed tomography (CT) scans for the primary evaluation of abdominal pain. Symptoms of PEA may, besides pain, include bloating and irregular bowel movements, though these are frequently associated with carbohydrate malabsorption syndromes. 2 We describe in a patient with PEA that the localized pain resolved within 3 weeks. Regression of inflammation including the reduction in size of the inflamed appendage in CT is demonstrated over the time period of 4 months. Owing to continuing symptoms with bloating and irregular bowel movements we investigated digestive disorders, and additionally a fructose malabsorption was diagnosed.
CASE HISTORY
A 31-year-old male Caucasian patient presented with a dull constant, localized and non-migratory pain in the left lower abdominal quadrant. Physical examination revealed localized tenderness, and his symptoms besides the pain included epigastric discomfort, bloating and semisolid stools two to three times per day. Laboratory parameters were leukocytes 10.1 × 10 9 /l (normal 4-10), C-reactive protein 46.8 mg/l (normal o8), fibrinogen 370% (normal 180-350), aspartate transferase 45 U/l (o35) and alanine transaminase 60 U/l (o45); all the other routine laboratory parameters, including erythrocyte sedimentation rate, liver and pancreas enzymes, were within normal limits.
An abdominal CT with intravenous contrast medium was performed and demonstrated an oval lesion, maximum diameter 2.7 cm, with a hyperattenuated rim, a central high-density dot and surrounding fat stranding, located adjacent to the sigmoid colon. These findings of the inflamed and thickened visceral peritoneum surrounding the fat-containing appendage as a hyperattenuating ring and the dot sign presumably caused by a thrombosed vessel completed the diagnosis of PEA (Figures 1a and b ). 3 Although it is known that most cases of PEA improve without therapy, 1 an outpatient therapy with metronidazole (500 mg twice daily) and pain treatment with the non-steroidal anti-inflammatory drug ibuprofen (600 mg twice daily) was initiated at an external institution. Within 3 weeks the patient's localized pain resolved but the bloating and semisolid stools recurred. After 2 months a control CT of the abdomen demonstrated regression of inflammation of the sigmoidal PEA with slight reduction in size to a maximum diameter of 2.4 cm; the hyperattenuated rim seemed reduced, and the surrounding fat stranding was not detectable any more (Figures 1c  and d ). Since this reduction of inflammation was seen and usually PEA resolves without treatment we started a close observation. Because abdominal discomfort, loose stools and bloating continued, an evaluation for other digestive disorders was begun.
Serum tests did not find antibodies against Helicobacter pylori and tissue transglutaminase. A hydrogen breath test for lactose and fructose intolerance was performed, although intolerance to lactose was not found. During a hydrogen breath test with a drink containing a 25 g fructose load the exhalation of H 2 was measured every 30 min for a period of 150 min. This test demonstrated a H 2 value of up to 51 p.p.m. and the diagnosis of fructose malabsorption was completed. Dietary intervention showed improvement of symptoms for 7 weeks; suddenly bloating and loose stools occurred again. The size of the inflamed appendage with a maximum diameter of 2.7 × 1.5 cm in the initial CT of the abdomen was reduced to 2.3 × 1.0 cm in the third abdominal CT after 4 months. Since the third CT of the abdomen demonstrated further improvement of inflammation of PEA (Figures 1e and f) a thorough evaluation of diet was performed. Within 2 days of accurate fructose-free diet the patient's complaints resolved and further recovery was uneventful. Written informed consent was obtained for all procedures, which were in accordance with the Declaration of Helsinki and the recommendations of the local ethics committee.
DISCUSSION
During the last few years, with the introduction of cross-sectional imaging and the increasing use of abdominal CT scans for primary evaluation of abdominal pain, the recognition of PEA has increased. Appendices epiploicae are pouches of subserosal fat lining the entire length of the colon. Normal epiploic appendages cannot be seen on CT scans. They are in two rows along the taenia libera and the taenia omentalis, except for the transverse colon with only one row, and are attached to the colonic wall by a vascular stalk. This explains why many cases of PEA are in the lower abdominal quadrants, particularly at the sigmoid colon. PEA is thought to be a localized sterile inflammation in and surrounding one epiploic appendage, and to arise primarily from a torsion causing ischemia and infarction with aseptic fat necrosis, and spontaneous venous thrombosis. CT is the diagnostic modality of choice for patients with suspected PEA because PEA has a characteristic appearance on CT.
3 Follow-up with abdominal CT of PEA has been reported in very few cases so far. [3] [4] [5] [6] [7] To the best of our knowledge we are the first to demonstrate reduction of inflammation and size of PEA with two follow-up CT evaluations over a time period of 4 months.
Owing to the lack of pathognomonic clinical features the diagnosis of PEA is difficult and rare. Symptoms include acute and recurrent non-migratory abdominal pain, local tenderness, intermittent febrile temperature and moderate weight loss. The pain is usually described as dull, constant, non-migrating, and physical examination reveals a well-localized tenderness. However, PEA pain may present in the same manner as any acute or subacute abdominal condition of the abdomen, such as diverticulitis, cholecystitis and appendicitis. It was suggested that patients treated for mild diverticulitis may have PEA, and it was reported that up to 7% of all patients clinically suspected of having diverticulitis may have PEA. 8 Abdominal bloating is a very common and troublesome symptom occurring at all ages. Bloating is usually associated with functional gastrointestinal disorders or organic diseases, but may also appear without known etiology. The pathophysiology of bloating remains vague and there are not enough data available for standardized efficient treatment of bloating. Carbohydrate intolerance, for example, lactose and fructose malabsorption, is frequently observed in patients with bloating and loose stools. Although bowel habits are usually not disturbed in PAE, a few reports have described complaints such as postprandial fullness, vomiting, bloating, constipation and diarrhea. [3] [4] [5] [9] [10] [11] [12] [13] [14] [15] Case collections demonstrated that diarrhea occurred in 25, 10 vomiting in 27 14 and 21 16 percent of patients with PAE. These values resemble the prevalence of carbohydrate malabsorption, with up to 30% reported for European populations. A diet free of triggering carbohydrates causes improvement of bloating and irregular bowel movements in a high percentage of patients. 17 
CONCLUSIONS
Appropriate diagnosis with CT allows a diagnosis of PEA and usually an outpatient treatment without medication or surgical treatment is successful within a few weeks. Symptoms such as bloating and irregular bowel movements in patients with PEA may be due to carbohydrate malabsorption and can be treated with a diet free of culprit carbohydrates. 
